Nonpregnant vaginal bleeding: Difference between revisions
No edit summary |
No edit summary |
||
| Line 42: | Line 42: | ||
#*Estrogen IV/PO (similar efficacy) | #*Estrogen IV/PO (similar efficacy) | ||
#Tranexamic acid <ref>Leminen and Hurskainen. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012; 4: 413–421.</ref> | #Tranexamic acid <ref>Leminen and Hurskainen. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012; 4: 413–421.</ref> | ||
#*1 g | #*Acutely 10 mg/kg IV, max dose of 600 mg<ref>Committee on Gynecological Practice. Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women. April 2013. http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/Management-of-Acute-Abnormal-Uterine-Bleeding-in-Nonpregnant-Reproductive-Aged-Women</ref> | ||
#*Then 1-1.5 g TID PO for 5 days | |||
#*Use only in women not at high risk for thrombosis | #*Use only in women not at high risk for thrombosis | ||
Revision as of 20:24, 4 November 2015
Background
- This page is for the generalized approach to undifferentiated vaginal bleeding in non-pregnant women
- Normal menstruation:
- 28 +/- 7 day cycles
- 4 days of bleeding
Vaginal bleeding definitions
- Menorrhagia: >7 day (prolonged) or >80 mL/day (excessive) uterine bleeding at regular intervals
- Metrorrhagia: irregular vaginal bleeding outside the normal cycle
- Menometrorrhagia: excessive irregular vaginal bleeding
- Intermenstrual bleeding: variable amounts between regular menstrual periods
- Midcycle spotting: spotting just before ovulation (due to decline in estrogen)
- Polymenorrhea: frequent and light bleeding
- Postcoital bleeding: vaginal bleeding after intercourse, suggesting cervical pathology
- Postmenopausal bleeding: recurrence of bleeding >6 mo after menopause
- Amenorrhea: bleeding that is absent for > 6 months
Clinical Features
- Vaginal bleeding in a non-pregnant woman
Differential Diagnosis
Nonpregnant Vaginal Bleeding
Systemic Causes
- Cirrhosis
- Coagulopathy (Von Willebrand disease, ITP)
- Group A strep vaginitis (prepubertal girls)
- Hormone replacement therapy
- Anticoagulants
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Hypothyroidism
- Polycystic Ovary Syndrome
- Secondary anovulation
Reproductive Tract Causes
- Adenomyosis
- Atrophic endometrium
- Dysfunctional uterine bleeding
- Endometriosis
- Leiomyoma (Fibroid)
- Foreign Body
- Infection (vaginitis, PID)
- IUD
- Neoplasia (especially in women >45 years old or in younger women with other risk factors)
- Vaginal Trauma
Diagnosis
Work-Up
- Urine pregnancy
- Hb
- Coags (only if h/o or suspect coaulopathy)
- ?TSH, prolactin (only if suspect endocrine d/o)
- Consider follow up for non-emergent pelvic ultrasound
- No indication for emergent ultrasound in ED
Evaluation
- Hemodynamically stable pt in ED must rule-out:
- Pregnancy
- Trauma
- Bleeding dyscrasia
- Infection
- Retained foreign body
- If ruled these out the refer for outpt w/u
Treatment
- Iron supplements
- Ibuprofen
- For cramps and theoretically decreases intra-uterine bleeding
- Hormones
- Give only if endocervical curettage/endometrial biopsy does not need to be performed (young patient) or has already been performed, as they may alter test results
- Medroxyprogesterone
- 150mg IM x 1 then 20mg PO Q8hrs x 3 days
- In a trial of 48 patients all had cessation in 5 days.[1]
- Estrogen IV/PO (similar efficacy)
- Tranexamic acid [2]
- Acutely 10 mg/kg IV, max dose of 600 mg[3]
- Then 1-1.5 g TID PO for 5 days
- Use only in women not at high risk for thrombosis
Life Threatening
- Give blood transfusion
- O-negative blood if emergent
- Establish good access
- Temporize bleeding w/ foley balloon or kerlix soaked in saline and thrombin
- Suture or silver nitrate if bleeding from trauma
Disposition
- Most can be discharged home with OB/GYN follow-up
- For severe anemia or persistent exceedingly heavy flow, consider admission and/or discussion with OB/GYN
References
- ↑ Ammerman SR, Nelson AL. A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study. Am J Obstet Gynecol. 2013. 208(6):499.e1-e5.
- ↑ Leminen and Hurskainen. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012; 4: 413–421.
- ↑ Committee on Gynecological Practice. Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women. April 2013. http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/Management-of-Acute-Abnormal-Uterine-Bleeding-in-Nonpregnant-Reproductive-Aged-Women
